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A B S T R A C T
5-Hydroxy-L-tryptophan (5-HTP) is a serotonin pathway metabolite of L-tryptophan in the brain. In the
knowledge that the biological properties of some compounds can be modified upon metal complexation, a new
solid metal complex, [Cu(5-hydroxytryptophan)2].H2O (Cu5HTP), has been synthesized and characterized to
analyze the modification of some biological properties. The conformational investigations (optimized in gas
phase at B3LYP/6-311G** theory level) suggest the coexistence of two conformers of Cu5HTP with cis- and trans-
arrangements of the amino acids in the equatorial plane. The trans- Cu5HTP1 complex is the most stable con-
former. The complexation led to an enhancement of the antioxidant properties of the ligand. The metal complex
also improved the anticancer behavior of the ligand (tested in cancer cell lines derived from human lung (A549),
cervix (HeLa) and colon (HCT-116)). It did not show toxicity against either the non-malignant human lung
fibroblast (MRC-5) cell line or Artemia salina and did not behave as mutagenic agent (Ames test). Cellular re-
active oxygen species production may be one of the possible mechanisms of action. Besides, the metal complex
exerted neuroprotective action on cortical neurons from embryonic 18 days rats exposed to glutamate.
1. Introduction
5-Hydroxy-L-tryptophan (5-HTP) is a serotonin pathway metabolite
of L-tryptophan in the brain that controls the concentration of ser-
otonin, and therefore plays a significant role in the serotonin pathway.
Besides, 5-HTP is a naturally occurring aromatic amino acid present in
the seeds of the African plant Griffonia simplicifolia and has been de-
scribed as an antioxidant agent [1]. Oxidative stress is caused by the
reaction of chemically aggressive oxygen species with biomolecules and
contributes to the development of some diseases. In plants, phenolic
compounds and carotenoids constitute the major tissue-protecting an-
tioxidants. Much less is known on antioxidant agents from animals. The
intertidal sponge which survives under intense sunlight, Hymeniacidon
heliophila, contains the antioxidant 5-HTP as major constituent. Other
known antioxidants such as flavonoids, carotenoids or tocopherol de-
rivatives were absent. Both the oxidation potential and the concentra-
tion of 5-HTP in H. heliophila correspond to the values observed for
flavonoids being the major antioxidants in plants [2]. Fig. 1 shows the
molecular structure of 2-amino-3-(5-hydroxy-1H-indol-3-yl) propanoic
acid (5-HTP).
Copper is an essential dietary nutrient for humans and other
mammalian species. The involvement of copper in human diseases has
been described from a medicinal-chemical and a biochemical view fo-
cusing on the molecular physiology of Cu transport. It is also now clear
that high or low body copper levels lead to severe pathological con-
sequences, as observed in Wilson and Menkes diseases. Several well-
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established symptoms of copper deficiency are related to alterations in
the activity of copper-dependent enzymes [3]. The excess of this es-
sential metal produced oxidative stress and the serum and tumor copper
levels were elevated in cancer patients in comparison with healthy ones
[4]. Copper ions are bound to ceruloplasmin, albumin and other pro-
teins. The copper redox capabilities and complexation potential makes
it indispensable for many cellular functions.
In many cases metal coordination leads to an improvement of the
pharmacological activities of the ligands and synergistic effects invol-
ving both metal and the ligands have been reported. The organic li-
gands could neutralize the electric charge of Cu(II), increase the lipo-
philicity of the complex, intercalate to DNA and/or interact with
different proteins. The use of copper complexes in medicine, and their
potential use as antimicrobial, antiviral, anti-inflammatory, antitumor
agents, enzyme inhibitors, has been reported during the last decades.
The complexes that showed different size, charge, electron affinity and
ability for adduct formation, could interact directly with proteins and
DNA, or indirectly producing reactive oxygen species (ROS) that attack
and degrade biomolecules [5].
We herein have investigated and characterized a new solid copper
complex [Cu(5-hydroxytryptophan)2]·H2O, Cu5HTP. Previous studies
on the interaction of 5-HTP with Cu(II) in solution have been performed
by fluorescence spectroscopy [6] and stability determinations [7].
Herein, we have prepared the solid complex which was characterized
by physicochemical determinations and the geometrical parameters
and IR-vibrational assignments have been determined by computational
methodologies.
To determine if the metal enhances the antioxidant activity of 5-
HTP, the in vitro antioxidant behavior of the compounds against DPPH•
(1,1-diphenyl-2-picrylhydrazyl) radical and the reactive oxygen species
(ROS) superoxide, hydroxyl and peroxyl has been measured. For the
determination of the biological effects of the metal complexes it is
crucial to assess the effects of the metal and the ligand under the same
experimental conditions. As far as we know, the biological effects of
metal complexes of 5-HTP have not been reported. Considering that
ROS can damage DNA and induced mutagenesis, we have initially de-
termined the anticancer effects and cellular ROS production on dif-
ferent cancer cell lines of the copper(II) cation, 5-HTP and Cu5HTP. We
have selected herein human lung cancer A549, human cervical cancer
HeLa and human colon cancer HCT-116 cell lines for the in vitro an-
ticancer determinations and cellular ROS production [8]. Lung cancer is
the primary cause of cancer-associated mortality in males and females
worldwide and although there are chemotherapeutic treatments, the
prognosis remains poor. It has been established that 90% of cases of
lung cancer belong to non-small cell lung cancer (NSCLC). Cervical
cancer constitutes the second most common cancer in women after
breast cancer, and the infection with one of the types (mainly types 16
and 18) of carcinogenic human papilloma virus (HPV) is associated
with high risk of cervical cancer. Colorectal cancer (CRC) is the third
most commonly diagnosed cancer in humans. Importantly, treatment of
lung fibroblast (MRC-5) cell line has also been tested to determine any
significant change in non-malignant human cells. The anticancer stu-
dies were coupled with the evaluation of the mutagenicity and acute
toxicity of all compounds.
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, mul-
tiple sclerosis and amyotrophic lateral sclerosis (ALS) are a group of
neurological conditions characterized by the loss of neuronal popula-
tions in the brain and/or spinal cord. Cognitive impairment, speech
difficulties and motor dysfunction are some of the symptoms that can
present these disorders [9]. As mentioned above, the synthesis of 5-HTP
from L-tryptophan is the first step of the biosynthesis of the neuro-
transmitter 5-hydroxytryptamine (5-HT) or Serotonin. Supplementation
with 5-HTP is hypothesized to normalize serotonin synthesis, crossing
the blood-brain barrier and increasing central nervous system synthesis
of serotonin. In addition to depression treatment the administration of
the amino-acid could be effective in the treatment of a variety of phy-
siological and pathological functions such as insomnia and chronic
headaches [10]. Glutamate is the predominant excitatory neuro-
transmitter in primary perception and cognition in the brain. It is re-
leased by presynaptic cells and acts on N-methyl-D-aspartate (NMDA),
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and
kainite (KA) receptors producing an excitatory response. When ex-
cessive amounts of glutamate are released or when glutamate clearance
is insufficient, neuronal death will result in a process with an excessive
activation of neuronal amino acid receptors known as excitotoxicity
[11,12]. Hence, the glutamate excitotoxicity has been associated to
various incurable diseases of the brain including Alzheimer’s [13] with
median survival of three years, affecting 5.4 people per 100,000 po-
pulations over year [14]. Disease-modifying therapy that prevents or
slows disease progression is still lacking, therefore there is an urgent
need to develop new therapies of neuroprotection against glutamate
toxicity. The reported neuroprotective effect exerted by the amino acid
Fig. 1. Structure of 2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid (5-HTP).
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taurine via anti-apoptosis in hypoxic-ischemic brain injury in neonatal
rats [15] is an example of the neuroprotective action of some amino
acids. In addition to the anticancer effects of the compounds we have
examined herein their potential neuroprotective effect by means of the
study of the signaling pathway in an established in vitro model of cen-
tral nervous system (CNS) injury induced by glutamate. The protocol
uses cortical neurons from embryonic 18 days rats and screened the
neuroprotective action of compounds by measuring cell counting, lac-
tate dehydrogenase release, caspase 3/7 activation and neurite out-
growth of each compound.
2. Materials and methods
2.1. Materials
All chemicals used were of analytical grade. Copper(II) chloride
dihydrate (CuCl2·2H2O), Copper(II) acetate monohydrate (Cu
(CO2CH3)2·H2O), para-nitrophenyl phosphate (p-NPP), solvents and all
the other analytical grade chemicals used were purchased from Merck.
5-hydroxytryptophan (C11H12N2O3) was obtained from Xi’an App-
Chem Bio(Tech) Co. Ltd. The growth medium (Mueller Hinton Broth
and Mueller Hinton Agar) was purchased from Brithania. Elemental
analysis for carbon, nitrogen and hydrogen was performed using a
Carlo Erba EA1108 analyzer. A Shimadzu system (model TG-50),
working in an oxygen flow of 50mL.min−1 and at a heating rate of
10 °C.min−1 has been used for the thermogravimetric analysis. Sample
quantities ranged between 10 and 20mg. UV–vis and diffuse re-
flectance spectra (MgO as a standard) were recorded with a Shimadzu
2600/2700 spectrophotometer. Infrared spectra were measured with a
Bruker IFS 66 FTIR spectrophotometer from 4000 to 400 cm−1 using
the KBr pellet technique. X-band CW-EPR spectra of powdered samples
were obtained at room temperature and 120 K on a Bruker EMX-Plus
spectrometer, equipped with a rectangular cavity with 100 kHz field
modulation. X band EPR spectra of frozen DMSO solutions were re-
corded at 120 K. EPR spectra were simulated with the EasySpin toolbox
based on MATLAB [16]. The molar conductance of the complex was
measured on a Conductivity TDS Probe - 850084, Sper Scientific Direct,
using 1× 10−3 M DMSO solution.
2.2. Synthesis of [Cu(5-hydroxytryptophan)2]·H2O, Cu5HTP
The ligand 5-hydroxytryptophan (1mmol) was dissolved in distilled
water (30mL) by heating and stirring. After cooling, an aqueous solu-
tion of Cu(CO2CH3)2 (0.5 mmol, 5 mL) was added to the ligand solution
under stirring during 5min. The light blue precipitate was separated by
filtration, washed three times with distilled water and dried in an oven
at 60 °C (see Scheme 1). The same product was obtained using CuCl2
instead of the acetate salt and adjusting the pH value to 5 by addition of
1M NaOH solution.
The solid product was characterized as [Cu(5-
hydroxytryptophan)2]·H2O (Cu5HTP). Anal. calc. for C22H24N4O7Cu: C
50.8, H 4.6, N 10.8%. Found: C 50.7, H 4.5, N 10.8%.
Thermogravimetric analysis (oxygen atmosphere, 50mL/min): The
complex starts decomposing gradually till it attains the temperature at
100 °C which corresponds to 1mol of hydrated water (Δωcalc = 3.5%,
Δωexp= 3.5%) in a single step process indicated by an endothermic
peak. At 800 °C the weight loss (84.7%, calc.; 85.0%, exp.) represents
the formation of CuO that was characterized by FTIR spectroscopy.
Diffuse reflectance spectrum: 360 nm (sh), 615 nm. UV–vis spectrum
(λm, 603 nm; ε, 94.2 M−1 cm−1; DMSO).
2.3. Computational methodology
Since suitable single crystals for structural determinations could not
be obtained, the geometrical parameters and the vibrational determi-
nations and assignments of Cu5HTP were studied by computational
methodologies. Theoretical calculations were performed using tools
from density functional theory (DFT) [17] as implemented in the
GAUSSIAN 09 program package [18]. The optimization procedures
were carried out using the Beck three-parameters hybrid exchange-
correlation functional, known as B3LYP [19] using the 6–311 G basis
set [20] reached by adding polarization functions.
The crystallographic data of 5-HTP [21] was used to build the
Cu5HTP complex. A conformational investigation of Cu5HTP with a
square-planar CuN2O2 coordination geometry (with two molecules of
the N,O-donor amino acid) was performed taking into account the cis
and trans conformations of the aliphatic nitrogen and a carboxylate
oxygen in the coordination sphere (CuN2O2). Besides, the rotation
around C2-C3 bond, defined as the dihedral angle C1-C2-C3-C4 (see
Fig. 1), was considered in the established models. This dihedral angle
configures the relative position of the plane of 5-HTP-rings system with
respect to the planar coordination sphere (CuN2O2). These calculations
were performed in gas phase combining different functionals (SVWN
and B3LYP) with different basis sets (3–21 G, 6–31 G, 6–31 G** and
6–311 G**). For the resultant structures of the conformational search
optimized at B3LYP/6-311** theory level, the harmonic vibrational
frequencies were calculated at the same level of theory. These calcu-
lations are necessary to confirm the presence of true minimum energy
structures, as well as to perform thermodynamic corrections (that are
included in all electronic energies reported) and to assign the theore-
tical vibrational spectra. The IR frequencies were analyzed by means of
Potential Energy Distribution (PED%) calculation using Vibrational
Energy Distribution Analysis (VEDA 4) program [22].
2.4. Antioxidant properties
The experimental conditions for the antioxidant determinations
were set according to previous reports [23]. The superoxide dismutase
(SOD) activity was examined indirectly using the nitroblue tetrazolium
(NBT) assay. The indirect determination of the activity of 5-HTP and
the Cu5HTP was assayed by their ability to inhibit the reduction of NBT
by the superoxide anion generated by the phenazine methosulfate
(PMS) and reduced nicotinamide adenine dinucleotide (NADH) system.
The concentration of compound that gave a 50% inhibition (IC50) was
obtained from the plot of the percentage of inhibition versus the nega-
tive log of the concentration. The capacity to scavenge hydroxyl radi-
cals (generated by the ascorbate-iron-H2O2 system) has been de-
termined by the measurement of the extent of deoxyribose degradation
by hydroxyl radical with the thiobarbituric acid method. The inhibition
of peroxyl radical was measured by generation of the radicals by the
thermal decomposition of 2,2-azobis (2-amidinopropane) dihy-
drochloride (AAPH). The delay of pyranine consumption (lag phase)
Scheme 1. Schematic representation of the reaction of synthesis
of Cu5HTP.
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was calculated as the time before the consumption of pyranine started
(notable reductions in absorbance). The antiradical activity of the
compounds was also measured in terms of their capacity to scavenge
DPPH• (1,1-diphenyl-2-picrylhydrazyl) radicals. Each experiment was
performed in triplicate and at least three independent experiments were
evaluated in each case.
2.5. Anticancer effects
2.5.1. Cell culture
Human lung cancer cell line A549, human cervical cancer cell line
HeLa and human colon cancer cell line HCT-116 were maintained at
37 °C in a 5% carbon dioxide atmosphere using DMEM supplemented
with 100 U/mL penicillin, 100 μgmL−1 streptomycin and 10% (v/v)
fetal bovine serum as the culture medium. Human fetal lung fibroblasts
(MRC-5 cell line) were grown as monolayer in DMEM supplemented
with 20% fetal bovine serum. When 70–80% confluence was reached,
cells were subcultured using TrypLE™ from Gibco (Gaithersburg, MD,
USA) and free phosphate buffered saline (PBS) (11mM KH2PO4, 26mM
Na2HPO4, 115mM NaCl, pH 7.4). For the experiments, cells were
grown in multi-well plates. When cells reached 70% confluence, the
monolayers were washed twice with DMEM and then incubated with
the different compounds.
2.5.2. Cell viability assay
For the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium
bromide) assay, A549, HeLa, HCT-116 and MRC-5 cells were seeded at
a density of 1×105 per well in 48 well plates, grown overnight and
treated with different concentrations of 5-HTP, Cu5HTP or copper(II)
cation in FBS free medium. Dimethyl sulfoxide (DMSO) has been used
as the dissolution vehicle to yield a maximum final concentration of
0.5% in each well (Sigma-Aldrich, St. Louis, MO). After 24 h incubation
at 37 °C, 100mg MTT (Sigma-Aldrich, St. Louis, MO) per well was
added and then incubated for 2 h. By cellular reduction of MTT for-
mazan products were generated. Formazan was dissolved in isopropyl
alcohol/HCl (cancer cell lines) or DMSO (normal cell line) and the
optical density was measured at 560 nm. All experiments were per-
formed in triplicate. Data were presented as percentage of cell viability
(%) of the treated group with respect to the untreated cells (control) in
which the viability is assumed to be 100%.
2.5.3. Cell morphology
To further evaluate the altered morphology induced by the copper
complex and the metal center, cells were grown in six well per plates
and incubated overnight with fresh serum-free DMEM without (control)
or with different concentrations of the complex. The monolayers were
subsequently washed twice with PBS, fixed with methanol and stained
with 1:10 dilution of Giemsa for 10min. Next, they were washed with
water and the morphological changes were examined by light micro-
scopy.
2.5.4. ROS measurements
Intracellular reactive oxygen species (ROS) generation in the A549,
HeLa, HCT-116 cell lines was measured by oxidation of 2′,7′-di-
chlorodihydrofluorescein diacetate (H2DCFDA) to 2′,7′-dichloro-
fluorescein (DCF). Briefly, 48-well plates were seeded with 5×104
cells per well and allowed to adhere overnight. Then, different con-
centrations of 5-HTP, Cu5HTP and copper(II) cation were added for 2
and/or 24 h. Afterwards, media was removed and cells were loaded
with 10 μM H2DCFDA diluted in clear media for 30min at 37 °C. Media
were separated and the cell monolayers rinsed with PBS and lysated
into 1mL 0.1% Triton-X100. The cell extracts were then analyzed for
the oxidized product DCF by fluorescence spectroscopy (excitation
wavelength, 485 nm; emission wavelength, 535 nm), using a Perkin-
Elmer LS 50B spectrofluorometer.
2.6. Toxicological assays
For the determination of the acute toxicity of CuCl2, 5-HTP and the
Cu5HTP in brine shrimp, eggs of A. salina were incubated in a hatching
chamber with artificial seawater at 20–30 °C (One liter of seawater
contains: NaCl, 23 g; MgCl2.6H2O, 11 g; Na2SO4, 4 g; CaCl2.2H2O, 1.3 g;
KCl, 0.7 g). The pH was adjusted to 9.0 using Na2CO3 to avoid risk of
death to the Artemia larvae by the decrease of pH during incubation
[24]. After 24 h, the larvae (nauplii) were extracted and counted using
a micropipette. Six concentrations of the compounds (in triplicate) were
tested in order to determine the dose-response relationship and nega-
tive (distilled water) and positive (K2Cr2O7) controls were used. The
selected concentrations tested were in the order of those used for the
anticancer determinations. The wells containing the sample and larvae
of brine shrimp, including the control groups, were filled to a total
volume of 100 μl with artificial seawater. After 24 h, live larvae were
counted and the median lethal concentration (LC50) values were esti-
mated.
Some chemical agents which show mutagenicity can induce cancer.
Then, it is useful to study the mutagenic potential of novel drugs.
Mutagenicity of the compounds was evaluated by the Salmonella/mi-
crosome assay that is based on the plate-incorporation method pro-
posed by Maron and Ames [25], using Salmonella typhimurium TA98 and
Salmonella typhimurium TA100. The test strains were obtained from
frozen culture and were grown overnight for 12–14 h at 37 °C in
Mueller Hinton broth. The different concentrations of CuCl2, 5-HTP and
the Cu5HTP (300, 150, 75, 37.5 and 18.8 μg/plate) were added to 2mL
of top agar mixed with 100 μl of bacterial culture (1–2×108 cells
mL−1) adding this mixture to a plate with minimal agar. These plates
were incubated at 37 °C for 48 h and the number of His+ revertant
colonies was counted. All experiments were made in duplicate. The
Mutagenic index (MI) was calculated as the average number of re-
vertants per plate divided by the average number of revertants per plate
from the negative control for each dose.
2.7. Neuroprotective signaling pathway
Primary cultures of cortical neurons were prepared from the cere-
bral cortices of Sprague-Dawley rat fetuses at embryonic day 18. Brains
were removed and freed from the meninges, and the tissues were then
dissected under a binocular microscope. Neurons were enzymatically
dispersed with trypsin 0.2% and DNAsa I 0.04% for 10min at 37 °C and
plated on poly-L-lysine wells with neurobasal medium supplemented
with B-27 supplement.
For the experimental assay of excitotoxicity induce by glutamate,
cortical neurons from embryonic 18 days rats were plated in poly-L-
lysine coated 96-well plates with a density of 3× 104 cells per well.
Cells were maintained in neurobasal medium supplemented with B-27
supplement for 8 days at 37 °C in a humidified 5% CO2 atmosphere. At
day 8, cells were pre-treated with compounds for 1 h in neurobasal
medium supplemented with B-27 supplement. After the treatments,
cells were washed and returned to compound-free medium for up to
48 h before being subjected to a glutamate excitotoxicity condition
where cells were incubated with 100 μM glutamate during 15min in
medium without B-27 supplement. After glutamate exposure, medium
was replaced by neurobasal medium supplemented with B-27 factor,
and then cells were incubated for an additional 24 h. Some cells were
treated as described above with 10 μM MK801 ((+)-5-methyl-10,11-
dihydro-5H-dibenzo(a,d)cyclo-hepten-5,10-imine) as positive control of
neuroprotection.
The neuroprotective effects were quantified by High Content Assay,
which included the following endpoints: plasma membrane integrity,
cell number, caspase 3/7 activation and neurite outgrowth. For the
determination of the plasma membrane integrity, the supernatants were
collected 24 h after treatments and lactate dehydrogenase LDH assay
was performed following the instructions of the kit manufacturer. Cell
J.J. Martínez Medina et al. Biomedicine & Pharmacotherapy 111 (2019) 414–426
417
viability was determined using Hoechst 33342 nucleic acid stain. Cells
were stained with 5 μg/mL of Hoechst 33342 dye, washed 3 times and
measured at 380 nm/460 nm Ex/Em. This dye allows a sensitive cell
number determination by fluorescence microscopy. Caspase 3/7 acti-
vation was determined using The CellEvent® Caspase-3/7 Green
Detection Reagent which is intrinsically a non-fluorescent peptide that
inhibits the ability of the dye to bind to DNA. However, after activation
of caspase-3/7 in apoptotic cells, the peptide is cleaved enabling the
dye to bind to DNA and produce a bright, fluorogenic response. Cells
were stained with 5 μM reagents, washed 3 times and measured at
488 nm/530 nm Ex/Em. This dye allows the direct quantification of
apoptotic cells.
Beta-III tubulin staining was determined by immunohistochemistry.
Once cells were stained and image with fluorescent dyes, cells were
washed with PBS and fixed with 4% paraformaldehyde for 15min.
After the fixation step the samples were washed three times with PBS
and permeabilized with PBS+0.3% triton for 10min. The samples
were then blocked with PBS+Bovine Serum Albumin (BSA) for 30min
and finally anti-tubulin III antibody were added at 1/1000 in
PBS+0.5% BSA for 60min at room temperature. After three washing
steps, the secondary antibodies Alexa 633 were added at 1/100 for
60min to react against the primary antibody. The samples were then
washed three times and measured in the Pathway 855 automated
fluorescent microscope. To investigate the role of neurite extension one
geometric pattern was employed in this study: neurite average length
per neuron. At the end of the assay, cells were firstly simultaneously
loaded with fluorescent dyes. After 1 h incubation at 37 °C with the
culture media containing the fluorescent probes, cells were imaged
using BD Pathway 855, and the attovision analyzer system was em-
ployed. Then, cells were fixed for beta-III tubulin staining and imaged
again using BD Pathway 855. In order to acquire enough cells for the
analysis, nine fields per well were imaged. The 20x objective was used
to collect images for the distinct fluorescence channels. Dyes were ex-
cited and their fluorescence was monitored at the excitation and
emission wavelengths with appropriate filter settings. In the setting up
of the procedure, exposure times were adjusted in order to avoid
overlapping emission between different probes. The collected images
were analysed using a module that allows the simultaneous quantifi-
cation of subcellular structures, which are stained by different mole-
cular probes and measure the fluorescence intensity associated with
predefined nuclear and cytoplasmic compartments.
2.8. Statistical analysis
Statistical differences were analyzed using the analysis of variance
method (ANOVA) followed by the test of least significant difference
(Fisher). Statistical significance was defined as p < 0.05.
3. Results
3.1. Solid characterization of the complex
3.1.1. Vibrational spectroscopy
The tentative assignments for the most important and characteristic
vibrational bands of the FTIR spectra for 5-HTP and Cu5HTP (in KBr
pellets) are displayed in Table S1. This assignment is based on some
previous reports of 5-HTP [26], L-Tryptophan [27] and the Copper(II)
L-Tryptophan complexes [28]. The presence of the characteristic
stretching and bending, ν(NH3+), δ(NH3+) and ν(COO−), bands in the
free ligand confirms the existence of 5-HTP in the zwitterionic form at
solid state and the broad bands at (2900-2600 cm-1 range) indicated
that H-bonds operate in the ligand. The vibration modes of the OH
group at C-5 appeared in the spectra of both for the ligand and the
complex. After complexation and deprotonation, the position of the
νas(NH2) and the νs(NH2) vibration bands supports the involvement of
this group in bonding [29]. The participation of the carboxylate group
on copper binding was also determined by the shift of the band posi-
tions. The antisymmetric and symmetric COO− stretching vibrations
(νas(COO−) and νs(COO−)) assigned to the 5-HTP (zwitterionic form)
shifted to lower frequencies upon coordination. The difference Δν=
νas(COO−) - νs(COO−), used as a criterion to establish the coordination
mode of the COO− group to the metal [30], resulted higher for the
complex (232 cm-1) than for the ligand (211 cm-1), in concordance with
a unidentate coordination mode of the carboxylate moiety. These re-
sults suggest that the coordination of the copper(II) ion with the 5-HTP
ligand most probably took place via carboxylate (COO−) and amino
(NH2) groups of the aminoacid. This conclusion is supported by solution
EPR determinations (see below).
3.1.2. EPR measurements
EPR and NMR spectroscopies are similar techniques but EPR de-
terminations concerned with the magnetically induced splitting of
electronic spin states, while NMR focus on the splitting of nuclear spin
states. The 1H NMR spectra of paramagnetic metal complexes are not as
well resolved as those of corresponding diamagnetic compounds. It is a
useful tool in studying the structural properties of Cu(II) coordination
compounds in solution, but the slow electronic relaxation of Cu(II) ions
usually results in large line widths and poor resolution of the spectra.
Furthermore, EPR spectroscopy is a powerful tool in the study of the
structures and environments of species that have unpaired electrons
like metal ions and organic free radicals. As the electronic analog of
NMR spectroscopy that probes the nuclear spin of molecules, it allows
the characterization of the geometry and electronic structure of the
copper(II) complexes [31]. This is the reason why we have selected this
technique to determine the environment and geometry of Cu5HTP
complex.
The EPR spectrum recorded for a powder sample of Cu5HTP to-
gether with the simulation measured at room temperature is displayed
in Fig. S1. The EPR spectrum shows axial g-values (gx = gy = g⊥ =
2.061, gz = g//= 2.226) typical for a Cu(II) species (S= 1/2) in
elongated octahedral, square pyramidal, or square planar geometries,
where the ground state is the dx2-y2 orbital [32]. A similar spectrum was
obtained at 120 K (data not shown). No resolved hyperfine structure
could be observable. This fact is compatible with the presence of in-
teraction between metal centers (typical of copper centers in an ex-
tended lattice), where the exchange interaction collapses the typical 4-
lines hyperfine interaction with the Cu(II) nucleus (I= 3/2). The low
value obtained for g// (g< 2.4) is in concordance with a square planar
geometry. These data were taken into account in order to perform op-
timization of the more reliable structure by DFT calculations.
3.1.3. DFT calculations
The conformational and structural analysis of Cu5HTP was carried
out without any constrains. The optimization procedures of the dif-
ferent conformers of Cu5HTP were performed employing different
functionals combined with different basis sets. Nevertheless, only five
structures converged at B3LYP/6-311G** and they are confirmed as
minimum energy structures (Fig. S2). The geometrical and energetic
aspects of the five conformers are listed in Table S2. The conformers 1
(trans) and 2 (cis) are the most stable conformers and they have an
energetic difference (ΔE) lower than 2 kcal mol−1 suggesting the co-
existence of both species at room temperature. The relative populations
of these two conformers were calculated by the Maxwell-Boltzmann
distribution at 298.15 K. The conformers 1 and 2 show relative popu-
lations close to 86% and 14%, respectively. These results led us to select
the structure of these two conformers in order to study their geome-
trical and vibrational aspects.
The metal center in the optimized structure of Cu5HTP1 presents a
square-planar CuN2O2 environment with a trans arrangement of the
amino acids in the equatorial plane, involving the terminal amino and
carboxylate groups of two molecules of 5-HTP. On the other hand, the
optimized structure of Cu5HTP2 indicates that this complex have the
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Cu(II) ion in a distorted square-planar geometry with a cis arrangement
of the aliphatic nitrogen and a carboxylate oxygen of the CuN2O2 en-
vironment. The Cu5HTP1 complex (trans) is the most stable conformer,
in agreement with previous reports of the parent aminoacid trypto-
phan/Cu(II) complex, Cu(Trp)2 [28]. Fig. 2 shows the optimized geo-
metry of the Cu5HTP1 and Cu5HTP2 complexes at the B3LYP/6-
311G** level of theory, including hydrogen atoms and numbers of the
atoms around the copper in the coordination sphere. Representative
bond lengths and angles around the copper atom in both conformers are
depicted in Table 1.
The experimental and the theoretical FTIR spectra of the Cu5HTP
complex, calculated at the same level of theory employed in the opti-
mization procedure (B3LYP/6-311G**), are shown in Fig. S3. The
theoretical FTIR spectra have been built weighting the spectra of
Cu5HTP1 (86%) and Cu5HTP2 (14%), attending the relative population
percentage of these two conformers calculated by the Maxwell-
Boltzmann equation (see Table 1). The results of our simulation em-
ploying different scaling factors [33] for different regions of the spec-
trum (frequencies< 1000=1.0119 and frequencies> 1000=
0.9682) are slightly different from the experimental data. Nevertheless,
this difference could be explained by the fact that the experimental
FTIR spectrum was measured in the solid state in which the structure is
subjected to intra and intermolecular interactions such us hydrogen
bonding and van der Waals interactions, whereas the calculations for
the isolated molecule have been performed in gas phase. In this context,
the Potential Energy Distribution (PED) analysis is an indispensable tool
for a serious analysis of the vibrational spectra. The analysis of vibra-
tional results was carried out employing VEDA 4 program in order to
identify the most important components in each vibrational mode with
a description using internal coordinates. The results of PED analysis for
Cu5HTP1 and Cu5HTP2 complexes are displayed in Table S3. The
contribution percentages of each coupled mode for the same wave-
number are indicated in parentheses.
3.2. Solution studies
3.2.1. Electronic spectra
The reported pK values for 5-HTP are: pK1 (−COOH)= 2.65, pK2
(-NH3+)= 9.63, pK3 (5−OH)= 10.68. The variation of the UV–vis
spectra of an aqueous solution of the aminoacid 5-HTP (5×10−5 M)
vs. pH agree with these values (Fig. S4 A). The stability constants for the
complexes Cu(HL) and Cu(HL)2 (logβ1, 8.61 and logβ2,15.76, respec-
tively) have also been reported [7]. It has to be noted that these values
were determined by different methods and showed slight deviations.
The electronic spectral pattern obtained from aqueous solutions of a
mixture of 5-HTP (1× 10-4 M) and CuCl2.2H2O (5× 10−5 M) at dif-
ferent pH values (Fig. S4C). Working with 100 times concentrated so-
lutions, the visible part of the electronic spectrum of the complex can be
detected. The electronic spectra of aqueous solutions of 5-HTP (1×10-
2 M) and CuCl2.2H2O (5× 10-3 M) at different pH values in the range
400 nm to 1000 nm are shown in Fig. S4D. At pH values lower than 3
the typical spectrum of [Cu(H2O)6]2+ complex can be observed
(λm=830 nm). Complex formation took place at pH 5–6 (λm=620
nm). At higher pH values new species and hydrolysis products have
been observed. Then, a pH value of 5 has been selected for the synthesis
of the complex.
There is a spectrum-structure correlation for copper(II) complexes
in aqueous solution that allow the calculation of the absorption max-
imum (nm) using estimated wavenumber coefficients:
∑=
=





Considering the Coefficient (νi) values for amino nitrogen (0.450)
and for carboxylate oxygen (0.353), the visible spectrophotometric
λmax value for equatorially-coordinated copper(II) complexes in aqu-
eous solution can be estimated. The calculated value of the electronic
absorption maximum was 623 nm. This value resembles that of the
diffuse reflectance spectrum (615 nm) and is similar, within the ex-
perimental error (10 nm), to the value obtained for an aqueous solution
at pH 5–6 of 620 nm (see supplementary data), indicating a metal en-
vironment of two N and two O atoms in the equatorial plane [34].
3.2.2. EPR spectrum in solution
It is well known [35] that EPR spectra of pure paramagnetic com-
pounds (i.e., systems in which the paramagnetic centers are not diluted)
are dominated by interactions between the metal centers and therefore
yield little information about the individual centers. In these cases, and
to gather information about the spectroscopic properties of the in-
dividual metal ion, solution or doped samples spectra have to be taken
Fig. 2. Geometry of the Cu5HTP1 (left) and
Cu5HTP2 (right) complexes optimized at the
B3LYP/6-311G** level of theory. The white
ball represents H atom, the black ball re-
presents N atom, the gray ball represents O
atom, the light gray ball represents C atom and
the big light gray ball represents Cu atom. The
atoms around the copper (atom 1) are num-
bered.
Table 1
Selected bond lengths (Å) and angles (°) around copper in the Cu5HTP1 and
Cu5HTP2 complexes calculated at B3LYP/6-311G** theory level.
Bond Lenghtsa Cu5HTP1 Cu5HTP2 Bond Anglesa Cu5HTP1 Cu5HTP2
Cu(1)-O(2) 1.904 1.937 O(2)-Cu(1)-N(3) 84.44 81.99
Cu(1)-O(4) 1.904 1.937 O(4)-Cu(1)-N(5) 84.44 81.99
Cu(1)-N(3) 2.010 2.042 O(2)-Cu(1)-N(5) 95.68 173.24
Cu(1)-N(5) 2.010 2.042 O(4)-Cu(1)-N(3) 95.68 173.24
O(2)-Cu(1)-O(4) 175.44 96.78
N(3)-Cu(1)-N(5) 176.97 100.00
a For the numbering of the atoms see Fig. 2.
J.J. Martínez Medina et al. Biomedicine & Pharmacotherapy 111 (2019) 414–426
419
to avoid the interactions between the metal ions. Because the solid EPR
spectrum of the complex showed interactions between the metal cen-
ters, the experimental EPR spectrum for a frozen solution of Cu5HTP at
120 K has been measured and the simulation was performed. From Fig.
S5 a nearly axial EPR spectrum can be seen (gx= 2.058, gy= 2.045,
gz= 2.249) with clearly resolved 4-lines hyperfine structure
(Ax= 12.9 G, Ay= 20.6 G, Az= 179.3 G) due to the interaction of the
unpaired electron spin with the Cu(II) nucleus (I= 3/2), results also
indicating a dx2-y2 ground state and the formation of a single mono-
nuclear species after dissolution. According to the Peisach Blumberg
correlation [36], the A// and g// values found in the simulation of the
spectrum are compatible with a copper(II) ion in a 2N-2O coordination
environment, in line with FTIR results. Furthermore, the frozen solution
EPR spectrum shows a five-line super-hyperfine splitting pattern at
B= 3265 G (g ≈ 2.068) (see inset on Figure S5), indicating that there
is, besides the interaction with the I= 3/2 of the copper nucleus, an
additional hyperfine interaction with two equivalent nitrogen (I= 1)
nuclei, tentatively assigned to two N atoms from two 5HTP ligands. As
shown in the inset on Figure S5, this N-hyperfine coupling was eval-
uated to be aN ≈ 12 G (≈ 11.6× 10−4 cm-1), compatible with values of
aN found in similar Cu(II) compounds. [37] It is worth to note that this
hyperfine coupling was not experimentally observed in all the spectral
features, indicating that the linewidth of the different hyperfine com-
ponents is not the same, which could not be reproduced in our simu-
lation. In any case, the hyperfine interaction attributable to two N
atoms is strong evidence that the proposed 2N2O solid state
coordination is kept in the DMSO solution.
3.2.3. Stability of the complex
The stability of Cu5HTP was measured in DMSO since this solvent
has been used as a co-solvent in the biological determinations. To test
the stability of the complex upon dissolution in DMSO, its rate of de-
composition was spectrophotometrically measured. The complex
(8×10−3 M) remained stable in a DMSO solution (no appreciable
changes were observed in the UV–vis spectra) at least during 1 h (data
not shown). The molar conductivity measurement of the complex has
been carried out in a 1mM DMSO solution. The obtained value (11 Ω-
1 cm2mol-1) revealed the non-electrolytic nature of the Cu5HTP com-
plex [38], indicating that the complex maintain its structure in solution.
This value remains unchanged during 24 h. Hence, by two different
experimental determinations it can be stated that the complex did not
decompose during the manipulation of the solution for the biological
studies.
3.3. Antioxidant determinations
The antioxidant properties of 5-HTP and Cu5HTP have been eval-
uated by means on the capacity of the compounds to scavenge reactive
oxygen species (ROS) in vitro. In addition, the capacity of the reduction
of the concentration of the DPPH% radical has been evaluated for
comparative purposes. 5-HTP did not display SOD activity whereas its
copper complex improved the capacity of dismutation of the superoxide
Fig. 3. Effects of 5-HTP (circles), Cu5HTP (triangles) and copper(II) cation (squares) on A549, HeLa, HCT-116 and MRC-5 cell line viability. The cell lines were
treated with various concentrations of the compounds for 24 h. The results are expressed as the percentage of the control level and represent the mean ± the
standard error of the mean (SEM) from three separate experiments (n= 15). * significant values in comparison with the control level (p < 0.05).
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anion showing a relevant activity (IC50= 4.8 μM) in comparison with
the activities of the CuCl2 (IC50= 3.6 μM) and native SOD (IC50= 0.21
μM) [39] (Fig. S6B). The aminoacid is not a good OH% scavenger and
Cu5HTP showed a moderate antioxidant activity against OH% radicals,
scavenging ca. 43% of the radicals at a 75 μM concentration (Fig. S6C).
Both 5-HTPand Cu5HTP were able to scavenge 89.4 and 91.3% of the
DPPH% radicals at 25 μM, respectively (Fig. S6D).
The 5-HTP aminoacid is able to prevent damage of biochemically
important molecules at physiological pH value. It acted as a naturally
occurring, endogenous antioxidant in marine organisms [2]. Our results
for 5-HTP showed that the amino acid behaved as a good scavenger for
reactive oxygen species (except superoxide anion) in agreement with
previous results [40] and the DPPH• radical-scavenging activity in-
dicated that 5-HTP has excellent hydrogen-donating ability. It has also
been reported that the ligand did not act as a prooxidant agent in the
linoleic acid/β-carotene-bleaching system, effect similar to that of the
synthetic antioxidant Trolox. Copper complexes with biologically active
molecules are being prepared as synthetic SOD mimics because of the
ability of copper to participate in redox reactions and to improve the
own limitations of the enzyme (lack of oral bioavailability, high mo-
lecular weight and low stability). Likewise, it has been reported that the
greater is the distortion in the geometry of the complexes the enhanced
effect on SOD activity [41]. Herein it can be seen that the copper
complexation enhanced the antioxidant activity of 5-HTP against all
radicals, and particularly, it was able to improve the scavenging action
against superoxide anion, as expected.
3.4. Anticancer effects
3.4.1. Cell viability
Cytotoxic effects of 5-HTP, Cu5HTP and copper(II) cation on ma-
lignant cell lines derived from human lung (A549), cervical (HeLa) and
colon (HCT-116) cancer are depicted in Fig. 3. The activity of the
compounds on non-malignant human lung fibroblast (MRC-5) cell line
was evaluated to demonstrate their selectivity towards malignant cells.
The natural aminoacid 5-HTP showed low cytotoxicity against the
tested cancer cell lines being the IC50 values> 100 μM. In the A549 cell
line, Cu5HTP displays a biphasic behavior, inducing an increase in cell
viability up to 100 μM and a cytotoxic effect at high concentrations (ca.
40% inhibition at 500 μM). However, in both HeLa and HCT-116 cell
lines the complex inhibited the cell viability in a dose-response manner
(ca. 50% inhibition at 100 μM). In agreement with previously published
assays, our results showed that copper(II) cation displayed insignificant
in vitro cytotoxicity [42].
A reasonable way of assessing anticancer activity in vitro is to test
the ability of drugs to kill cancer cells without significantly affecting
nonmalignant cells. To determine if the compounds were able to kill
cancer cells selectively at concentrations that do not significantly affect
the healthy cells, the MRC-5 cell line has been selected. From Fig. 3 it
can be seen that the compounds did not show toxicity against the fi-
broblast normal line. The results for CuCl2 agree with previous de-
terminations [43]. Moreover, these compounds did not show either
toxicity by the Artemia salina test or mutagenic effects by the Ames
assay (see below).
3.4.2. Morphological changes
An inverted microscope was used to examine cell morphology al-
terations by Giemsa staining (Fig. 4A and B). The morphological
changes after addition of Cu5HTP are shown in Fig. 4A. The analysis for
A549 cells showed the expected pebble-like shape, close cellular ad-
hesion and clear cell boundaries [44]. Upon 500 μM Cu5HTP treatment
morphological changes such as cell shrinkage and pyknotic nuclei can
be observed. Untreated HeLa cells showed typical rhomboid-tetrahedral
shape and pleomorphic nuclei [45] and after Cu5HTP treatment,
especially at 100 μM, shrinkage, nuclear condensation elongated la-
mellipodia and many detached cells can be observed. Defined nuclei
and presence of nucleoli is the typical morphology of HCT-116 cells
[46]. Morphological changes like condensed nuclei and cell shrinkage
were observed when 100 μM of the complex was added. In all three
cases, the decrease in the number of cells is in agreement with the MTT
assay. To discard that the morphological changes of immortalized cell
lines treatment could be due to the dissociation of the complex and the
release of copper ions, a control experiment post CuCl2 incubation has
been performed (Fig. 4B). It can be observed that the metal, at con-
centration 100 μM, did not affect the morphology (shape and size) of
the nucleus and the cytoplasm in the three cell lines. In the HeLa cell
line a slight decrease in the number of cells was detected. The results
are in agreement with the observations in the cell viability test. please
change the color of the table from red to black
3.4.3. Intracellular ROS production
The mechanism of action of many chemotherapeutic agents is based
on the reactive oxygen species (ROS) generation. It is known that
cancer cells possess certain characteristics different from the normal
cells such as increase in metabolic rate, ROS generation and decrease in
ROS elimination processes [47]. While high levels of ROS can induce
damage in macromolecules such as lipids, proteins and DNA, low levels
can act as cellular signaling messengers [48]. To investigate the pos-
sible production of ROS in A549, HeLa and HCT-116 cell lines, cells
were incubated with different concentrations of the compounds during
24 h. For the A549 cell line it can be observed that there are no dif-
ferences with respect to the control working with concentrations up to
100 μM (Fig. 5). At concentrations higher than 250 μM the compounds
produced a slight decrease in ROS production. Conversely, 5-HTP did
not show differences with the control cells. The behavior on ROS pro-
duction of both 5-HTP and CuCl2 is similar in HeLa and HCT-116 cell
lines, Fig. 5, generating a slight increment in ROS levels. On the other
hand, Cu5HTP induced an increment in intracellular ROS levels in both
cells line in a dose-dependent manner (ca. 160–170 % at 100 μM).
These results are in agreement with the cell killing effects of the metal
complex in the human cervical and human colon cancer cell lines.
Considering that in the human lung cancer cell line the compounds
produced a reduction in cell viability (at concentrations> 100 μM)
associated with a decrease of intracellular ROS levels, we have per-
formed the experiment of ROS measurements reducing the incubation
time. The A549 cell line was incubated with 250 and 500 μM con-
centrations of the compounds for 2 h. An increase in ROS production in
a dose-dependent manner was observed for CuCl2 and Cu5HTP (Fig. 6)
showing that ROS could be initiated at shorter times and that it is
significantly associated with the cell death observed at 24 h incubation
(Fig. 3). At concentrations lower than 100 μM, no cellular ROS pro-
duction was detected.
Our results showed that the complex improves the activity of the
natural aminoacid on the three tested tumor cell lines without affecting
the normal fibroblast viability, being the oxidative stress one of the
possible mechanisms of action.
3.5. Toxicological assays
Once the lack of toxicity of the compounds in the normal cell line
has been determined, the study of their possible toxic effects can be
extended through the Artemia salina L. test. This assay is useful for the
screening of novel drugs in order to predict their toxicity and has shown
a good correlation (r= 0.85 p < 0.05) with the assays in mice, sug-
gesting that the brine shrimp bioassay is a useful alternative model
[49]. The mortality of brine shrimp produced by Cu2+ has previously
been reported [50] and is slightly different from our data
(LC50= 89.76 μg mL−1). These differences could be due to the different
methodologies, experimental conditions (especially the copper salt and
the composition of sea water used) and the strain of eggs. On the
contrary, 5-HTP and the Cu5HTP complex did not produce dead nauplii
at the tested concentrations, thus suggesting that these compounds did
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not exert toxic effects.
On the other hand, the Ames Salmonella typhimurium assay has been
used to identify substances that can produce genetic damage that leads
to gene mutations. The test uses Salmonella strains with preexisting
mutations that are not capable to synthesize histidine, and then are not
able to grow or form colonies in its absence. Compounds with
Fig. 4. Morphological changes of A549, HeLa and HCT-116 cells after treatment with A) Cu5HTP and B) CuCl2, respectively, for 24 h. Control cells remained
untreated and received an equal volume of the solvent. Representative images (100X magnification) by inverted microscope. Fig. 4A includes the scoring of
morphological changes: Normal (-), in between normal and mild (+), mild (++), moderate (+++) and sever (++++). This scoring is negative for Fig. 4B (CuCl2
treatment).
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mutagenic potential may restore the genes function (reversion assay).
Consequently, a positive test indicates that the compound is mutagenic
and therefore may act as a carcinogen. A sample was considered posi-
tive when the mutagenic index (MI) was equal or greater than 2 for at
least one of the tested doses and if it had a reproducible dose-response
curve [25]. It can be seen in Table S4 that the CuCl2, 5-HTP and the
Cu5HTP complex did not exert mutagenic action on the tested strains.
In agreement with our data, the absence of mutagenic activity of Cu2+
(as the perchlorate salt) in the Ames test employing S. typhimurium
TA98 and S. typhimurium TA100 (with metabolic activation) was pre-
viously reported [51]. The mutagenic index value (lower than 2) in all
the cases showed that the tested substances could not induce an in-
crease in the number of revertants. These results indicated that the
tested compounds did not induce frameshift mutations (S. typhimurium
TA98) or base-pair substitution mutations (S. typhimurium TA100) at
the tested concentrations.
3.6. Neuroprotective effects
To assess the effects of glutamate on plasma membrane integrity,
LDH quantification in supernatants of treated and untreated cells was
employed. As shown in Fig. 7A, exposure to 100 μM glutamate for
15min induced a significant increase (ca. 300%) in LDH release com-
pared to the control untreated cells. No differences of less than 20%
were observed with any of the compounds except with the compound
Cu5HTP at 0.1 μM which decreased the production of LDH induced by
glutamate by 30%. These findings meant a clear neuroprotective im-
provement against 5HTP and CuCl2.
N-Methyl-D-aspartate (NMDA) receptors produce the activation of
specific calcium-dependent signaling cascades which allows the
regulation of functional and structural plasticity of individual synapses,
dendrites and neurons. The co-agonists Glutamate and glycine must
bind the receptor to activate it opening the ion channel. MK801 is a
noncompetitive antagonist that blocks the ion channel by binding to
allosteric sites and is used to prevent neuronal degeneration caused by
N-Methyl-D-aspartate (NMDA). From Fig. 7A it can be seen that MK801
behaves like untreated cells (control cells), which confirmed that the
toxicity on cortical neurons was due to the glutamate action [52]. In
order to quantify cell number Hoechst 33342 staining was used
(Fig. 7B). Glutamate treatment resulted in 45% of mortality in neurons
when measured 24 h after exposure. On the other hand the known
neuroprotective molecule MK801 prevents OGD-induced mortality by
22%. Glutamate-induced cell death could be also prevented by appli-
cation of the 5-HTP at 0.1 μM and by application of Cu5HTP at all the
concentrations tested. Therefore, compounds supplementation sig-
nificantly reduced cell death and improved survival of neurons. Again,
it was observed a clear neuroprotective improvement of Cu5HTP
compound against 5-HTP. No neuroprotection in cell number was ob-
served with the compound CuCl2.
To examine whether glutamate-induced cytotoxicity is mediated by
apoptotic processes, caspases 3/7 activation assay was measured
(Fig. 7C). Glutamate treatment resulted in a 4.5 fold- increase of cas-
pase 3/7 activation in neurons when measured 24 h after exposure
whereas the neuroprotective positive control MK801, prevented OGD-
induced apoptosis by 60%. Glutamate induced caspase 3/7 activation
could be also prevented by the application of Cu5HTP in all the con-
centrations tested (0.1, 1 and 10 μM) by 60% while the 5-HTP com-
pound could only protect at the highest tested concentration (10 μM).
Therefore, compounds supplementation significantly reduced caspase
3/7 activation and improved survival of neurons. Again, it was ob-
served a clear neuroprotective improvement of Cu5HTP compound
against 5-HTP. On the other hand, no neuroprotective effect in caspase
3/7 activation was observed with CuCl2 compound and it was even
toxic increasing caspase 3/7 activation at the highest concentrations (1
and 10 μM).
To investigate the ability of the compounds that affects the growth
of neurite, a geometric pattern was mainly employed: the neurite
average branch length per neuron. Fig. 7D showed that glutamate
treatments resulted in a decrease of 55% in neurite outgrowth com-
pared to untreated cells. Glutamate induced neurite outgrowth reduc-
tion could be prevented by application of Cu5HTP by 27 and 37% at 0.1
and 1 μM respectively while 5-HTP could only protect at the lowest
tested concentration (0.1 μM). Again, it was observed a clear neuro-
protective improvement of Cu5HTP compound against 5-HTP. On the
other hand, no neuroprotective effect was seen with CuCl2 compound.
Therefore, it the present study, the preventive effects shown by
Cu5HTP and 5-HTP against glutamate toxicity are associated with in-
crease of cell number, restoration of caspase 3/7 activity, stabilization
of neurite outgrowth and a decrease of LDH secretion. Both compounds
Fig. 5. Effects of 5-HTP (circles), Cu5HTP (triangles) and copper(II) cation (squares) on H2DCFDA oxidation to DCF at 24 h. A549, HeLa and HCT-116 cells were
incubated at 37 °C in the presence of 10 μM H2DCFDA. The values are expressed as the percentage of the control level and represent the mean ± SEM (n=15). *
significant values in comparison with the control level (p < 0.05).
Fig. 6. Effects of 5-HTP, Cu5HTP and copper(II) cation on H2DCFDA oxidation
to DCF on A549 cell line at 2 h. The values are expressed as the percentage of
the control level and represent the mean ± SEM (n=15). * significant values
in comparison with the control level (p < 0.05).
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attenuated the toxic effects of glutamate on caspase, cell death, and
neurite outgrowth but Cu5HTP compound possessed higher neuropro-
tective capacity than 5-HTP.
4. Discussion
In this paper we have designed and studied a new copper(II) com-
plex with the antioxidant ligand 5-HTP and shown the synthesis and the
detailed characterization. Using different spectroscopic techniques we
have established the (N,O) chelating nature of the ligand both in solid
state and in solution.
In accordance with generalized EPR data of copper(II) bis-ami-
noacid complexes the calculated EPR parameters help to define the
geometric isomerism (cis- or trans-) of the complex. The value of the
hyperfine coupling constant obtained from the solution EPR spectrum
of Cu5HTP resulted between the values of both type of isomers (A//
= 171 and 201 G and A┴=16 and 32 G for trans-CuN2O2 and cis-
CuN2O2 complexes, respectively [53], but closer to the trans- isomer
(Fig. 2) indicating that this conformer should be the majority species in
solution. These results confirm the findings that correlate the vibra-
tional DFT studies and the experimental FTIR spectra in solid state.
The aminoacid acts as a naturally occurring, endogenous anti-
oxidant in the intertidal sponge Hymeniacidon heliophila. This com-
pound is present in the animal in the concentration range of other well-
known antioxidants like flavonoids in plants (ca. 10mM). Its
antioxidant activity has previously been determined at 10mM con-
centration regarding the protection exerted by the compound on human
monocytes against UV-induced apoptosis (apoptosis caused by stress
oxidative) [2]. Moreover, in the present study it has been determined
that 5-HTP showed a good radical-scavenging activity against ROO%
and DPPH%, but not against superoxide anion and OH% radical (at least
at concentrations up to 75 μM). Previous reports showed that hydroxyl
radicals were effectively scavenged by the ligand but agree that it has
no effect on the superoxide radicals [2] and that the antioxidant effect
of the aminoacid may be due to the active hydrogen-donating ability of
hydroxyl substitution. In the knowledge that the biological activities of
an organic ligand can be increased when coordinated with suitable
metal ions, we found that the copper complex behaved as a more potent
free radical-scavenging agent enhancing the antioxidant capacity of 5-
HTP.
The anticancer effects of the compounds were checked by means of
the measurements of the growth inhibitory efficacy in cancer cell lines.
The complex Cu5HTP resulted more effective against human cervical
(HeLa) and human colon (HCT-116) cancer cell lines than on human
lung cancer (A549) cell line. Therapeutic effects of anticancer drugs on
tumor cells are associated with various unwished toxic effects on non-
tumor cells like hair loss, cardiac anomalies, bone narrow toxicity,
nausea and vomiting. Herein we show the lack of toxicity at the tested
concentrations for the ligand and its copper complex using different
assays: on a non-malignant human lung fibroblast (MRC5) cell line, the
Fig. 7. Primary cortical rat neurons were pre-treated with 5-HTP, Cu5HTP and CuCl2 at different concentrations (0.1, 1 and 10 μM) for 1 h. After 48 h, neurons were
exposed to 100 μM of glutamate (Glu) for 15min. The effects of the compounds were quantified by (A), lactate dehydrogenase (LDH) release (B) changes in nuclear
morphology (Hoechst-staining) (C) caspases 3/7 activity (apoptosis) (D) neurite outgrowth. 10 μM of MK801 was used as positive control of neuroprotection. The
results are expressed as the percentage of the basal level and represent the mean ± the standard error of the mean (SEM) from three separate experiments (n= 9). *
significant values in comparison with the control level (p < 0.05).
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effect against Artemia Salina and the Ames test. Hence, their anticancer
activity has been correlated well with tumor-specificity (higher cyto-
toxicity against tumor cells versus normal cells).
Non-transformed cells (like MRC-5 cell line) have a lower basal
intracellular ROS level, and have a full antioxidant capacity, being less
vulnerable to the oxidative stress induced by different compounds in
cancer cells. Cancer cells have higher levels of ROS than normal cells
and controlled ROS levels exert a pro-survival effect in cancer cells. But,
under ROS stress, malignant cells could induce apoptosis or necrosis
[54]. It has previously been reported that the pro-oxidant nature of the
complexes is manifested mainly in the cancer cells, the mechanism of
which is still unclear.
The observation of elevated ROS in the cell lines in the presence of
Cu5HTP is an evidence of a mechanism of action involving oxidative
stress. Notably, the compound displayed the highest activity by gen-
eration of the highest cellular level of ROS in vitro and hence, the cy-
totoxicity of the complex resulted greater than either the 5-HTP ligand
or free Cu(II). This may indicate that the ligand plays a role in enabling
the copper centers to effectively generate elevated levels of toxic ROS,
giving rise to cell death.
As it is known that 5-HTP is involved in the biosynthesis of the
neurotransmitter Serotonin and that glutamate excitotoxicity is in-
volved in many neurodegenerative diseases we have also studied the
neuroprotection of the compounds on neuronal injury in cell culture
after exposure to glutamate. LDH is a ubiquitous cytoplasmic oxidor-
eductase which is used as biochemical index of neuronal injury [55].
The lowest tested concentration of the complex and the highest of the
ligand decreased the LDH release which implies that the compounds
protected the cells against glutamate-induced cytotoxicity, being
Cu5HTP more effective than 5-HTP. The results are in agreement with
those obtained by the Hoechst assay. It is known that neuronal cell
death induced by glutamate can occur through the disruption of in-
tracellular calcium homeostasis followed by mitochondrial uncoupling
and activation of the intrinsic mitochondrial apoptosis pathway by
triggering caspases activation [56]. In this work, we have shown that
Cu5HTP (at the three tested concentrations) decreased caspase 3/7
activity like the NMDA receptor antagonist, MK801. The aminoacid 5-
HTP only showed this effect at 10 μM concentration. The current results
suggest that Cu5HTP and to a lesser extent 5-HTP, exerted neuropro-
tection against Glu-induced excitotoxicity in primary cultures of cor-
tical neurons, due in part to the to its anti-apoptotic effect, like the
aminoacid taurine [15]. After an injury, the central nervous system of
adult mammals has limited capacity to regenerate due to insufficient
stimulation of a growth response following injury, the release of growth
inhibitory molecules from myelin and the formation of scar tissue at the
site of injury [57]. Neurite outgrowth is a process involved in the brain
development and it is related to the synaptic structure, characteristics
of information transmission efficiency and neuronal synaptic plasticity
[58]. In addition to neuroprotection, for the damaged brain to restore
normal physiological functions, the reorganization of the lost neuronal
network is indispensable. Taking into account that the complex induced
neurite extension in cortical neurons and exerted preventive effects
demonstrated by the decrease of the LDH release and the increase in the
cell number, through a caspase dependent mechanism, Cu5HTP could
be considered as a potential neuroprotective agent against glutamate
induced cell-death. While the biometal did not exert protective effects,
the ligand showed protective effects at some of the tested concentra-
tions.
5. Conclusions
The 5-hydroxytryptophan Copper(II) complex (Cu5HTP) has been
synthesized and characterized by elemental analysis, thermogravi-
metric analysis, spectroscopic techniques, and computational studies.
The conformational investigations of the solid complex suggest the
coexistence of two conformers of Cu5HTP with cis- and trans-
arrangements of the amino acids in the equatorial plane (optimized in
gas phase at B3LYP/6-311G** theory level) at room temperature. The
Cu5HTP1 complex (with trans- configuration) is the most stable con-
former. The biological activities of the metal complex resulted en-
hanced with respect to the ligand. Copper(II) complexation enhances
the antioxidant properties of 5-HTP. The complex showed improved
anticancer effects by means of a pro-oxidant mechanism in cancer cells.
The neuroprotective action of the complex on neuronal injury in cell
culture after exposure to glutamate resulted more effective than that of
5-HTP. The ligand and the complex did not exert toxic effects against
Artemia salina and did not behave as mutagenic agents indicating that
these compounds have the potential to act as effective antioxidant
drugs. In this context, we can conclude that some biological properties
have been modified upon complexation with copper(II) and this com-
plexation may provide a promising strategy for the development of
novel and more secure anticancer and neuroprotective drugs with an-
tioxidant properties.
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